Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$986K Buy
2,483
+505
+26% +$144K 0.01% 356
2026
Q1
$343K Sell
1,978
-154
-7% -$31.6K ﹤0.01% 608
2025
Q4
$546K Sell
2,132
-396
-16% -$104K 0.01% 475
2025
Q3
$658K Buy
2,528
+294
+13% +$77.3K 0.01% 439
2025
Q2
$546K Sell
2,234
-88
-4% -$21.9K ﹤0.01% 463
2025
Q1
$614K Buy
2,322
+266
+13% +$71.9K 0.01% 446
2024
Q4
$522K Sell
2,056
-892
-30% -$239K ﹤0.01% 495
2024
Q3
$934K Sell
2,948
-712
-19% -$253K 0.01% 346
2024
Q2
$1.37M Buy
3,660
+1,165
+47% +$393K 0.01% 245
2024
Q1
$865K Sell
2,495
-1,160
-32% -$440K 0.01% 329
2023
Q4
$1.67M Sell
3,655
-4
-0.1% -$1.97K 0.02% 202
2023
Q3
$1.78M Sell
3,659
-200
-5% -$94K 0.02% 176
2023
Q2
$1.73M Sell
3,859
-679
-15% -$342K 0.02% 182
2023
Q1
$2.2M Buy
4,538
+106
+2% +$52.4K 0.02% 153
2022
Q4
$2.27M Buy
4,432
+11
+0.2% +$5.78K 0.03% 147
2022
Q3
$2.15M Buy
4,421
+213
+5% +$104K 0.03% 140
2022
Q2
$1.97M Buy
4,208
+60
+1% +$26.7K 0.03% 133
2022
Q1
$1.8M Buy
4,148
+956
+30% +$400K 0.02% 152
2021
Q4
$1.48M Buy
3,192
+316
+11% +$140K 0.02% 174
2021
Q3
$1.12M Sell
2,876
-44
-2% -$18.7K 0.01% 212
2021
Q2
$1.29M Buy
2,920
+35
+1% +$15.3K 0.02% 182
2021
Q1
$1.21M Buy
2,885
+329
+13% +$131K 0.02% 181
2020
Q4
$1.05M Buy
2,556
+35
+1% +$14.6K 0.01% 175
2020
Q3
$1.04M Buy
2,521
+65
+3% +$26.1K 0.02% 158
2020
Q2
$952K Buy
2,456
+402
+20% +$150K 0.02% 165
2020
Q1
$645K Buy
2,054
+69
+3% +$23.3K 0.01% 183
2019
Q4
$728K Sell
1,985
-34
-2% -$10.8K 0.01% 214
2019
Q3
$516K Buy
2,019
+367
+22% +$103K 0.01% 278
2019
Q2
$438K Buy
1,652
+55
+3% +$13.9K 0.01% 310
2019
Q1
$425K Sell
1,597
-91
-5% -$26.2K 0.01% 296
2018
Q4
$484K Buy
1,688
+106
+7% +$33.6K 0.01% 261
2018
Q3
$536K Buy
1,582
+97
+7% +$31.5K 0.01% 270
2018
Q2
$442K Buy
1,485
+393
+36% +$115K 0.01% 296
2018
Q1
$294K Buy
1,092
+106
+11% +$28.7K 0.01% 343
2017
Q4
$245K Buy
986
+85
+9% +$21K 0.01% 393
2017
Q3
$220K Buy
+901
New +$221K ﹤0.01% 378

Other funds holding HUM

Greenleaf Trust's HUM Position: Q2 2026 in Review

Greenleaf Trust increased its Humana (HUM) stake by 26% in Q2 2026, buying an estimated $144K and bringing the position to 2,483 shares worth $986K. The position accounts for 0.01% of the portfolio, ranked #356.

Greenleaf Trust first reported a position in HUM in Q3 2017 and has held it in 36 quarters since. The position peaked at $2.27M in Q4 2022. 191 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Greenleaf Trust held 2,483 shares of Humana worth $986K as of Q2 2026.
  • Greenleaf Trust bought 505 Humana shares in Q2 2026, an estimated $144K.
  • Humana made up 0.01% of Greenleaf Trust's portfolio in Q2 2026, its #356 holding.
  • Greenleaf Trust first reported a position in Humana in Q3 2017 and has held it in 36 quarters since.
  • Greenleaf Trust's Humana position peaked at $2.27M in Q4 2022.
  • 191 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.